HB2218 — Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act.

HB2218 — Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act. · Informed CitizenryHB 2218 amends the uniform controlled substances act by making two key changes regarding psilocybin. First, it amends K.S.A. 2024 2025 Supp. 65-4101 to define "Psilocybin" so that it does not inclu…Open in Informed Citizenry